ArticleBMJ global health2019
Quality of medical products for diabetes management: a systematic review.
Article in BMJ global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality.BMJ global health · 2020Pooled it
- Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional survey.EClinicalMedicine · 2025Article
- 'Prevalence, experience and awareness of substandard and falsified medicines among the public and healthcare professionals in Jordan'.BMJ global health · 2025Article
- Hide and seek with falsified medicines: Current challenges and physico-chemical and biological approaches for tracing the origin of trafficked products.Forensic science international · 2025Review
- Smartphone-Assisted Thin-Layer Chromatography for Rapid Quality Screening of Metformin.Advances in pharmacological and pharmaceutical sciences · 2025Article
- Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya's pharmacovigilance database.BMC public health · 2024Article
- Quality of Essential Medicines from Different Sources in Enugu and Anambra, Nigeria.The American journal of tropical medicine and hygiene · 2024Article
- A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines.PLOS global public health · 2024Article
- Variation in Price of Cardiovascular and Diabetes Medicine in Indonesia, and Relationship with Quality: A Mixed Methods Study in East Java.The American journal of tropical medicine and hygiene · 2023Article
- The quality of antiretroviral medicines: an uncertain problem.BMJ global health · 2023Article
- A study of the quality of cardiovascular and diabetes medicines in Malang District, Indonesia, using exposure-based sampling.BMJ global health · 2022Article
- Article
- Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?BMJ global health · 2022Article
- The quality of veterinary medicines and their implications for One Health.BMJ global health · 2022Article
- Review
- Patients Access to Medicines - A Critical Review of the Healthcare System in Kenya.Risk management and healthcare policy · 2022Review
- The quality of medical products for cardiovascular diseases: a gap in global cardiac care.BMJ global health · 2021Article
- Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward.BMJ global health · 2020Article
- Article
- Medicine quality in high-income countries: The obstacles to comparative prevalence studies.Medicine access @ point of careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe global prevalence of diabetes mellitus is increasing alarmingly. However, the quality of vital medicines and medical products used to treat and monitor diabetes remains uncertain but of potential great public health significance. Here, we review the available evidence on the quality of antidiabetic medicines and supplies for self-monitoring of blood glucose (SMBG) and discuss their potential impact for the patients and society.
methodsSearches were conducted in PubMed, Embase, Google Scholar, Google and relevant websites in English and French. The Medicine Quality Assessment Reporting Guideline (MEDQUARG) was used to assess the quality of medicine quality surveys.
results52 publications on the quality of antidiabetic medicines, including 5 medicine quality prevalence surveys and 20 equivalence studies, were analysed. The prevalence surveys and equivalence studies included 674 samples of which 73 (10.8%) were of poor quality. The median (Q1-Q3) concordance with MEDQUARG items was 30.8% (19.2%-42.3%). No prevalence surveys on SMBG supplies' quality were found, but 29 publications, including falsified products and incorrect results due to strip degradation or contamination, were identified.
conclusionThere is little accessible evidence on the quality of antidiabetic medicines and SMBG supplies. Surveys were poorly designed and reported, making data aggregation and interpretation problematic. Despite these caveats, these results suggest that there are important issues with the quality of medical products for diabetes that need focused monitoring. There is an urgent need to achieve consensus protocols for designing, conducting and reporting medical product quality surveys. PROSPERO REGISTRATION NUMBER: CRD42016039841.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.